A cardiotoxicity dataset for breast cancer patients

This dataset is a result of the collaboration between the University of A Coruna and the University Hospital of A Coruna. It contains information about 531 women diagnosed with HER2+ breast cancer, treated with potentially cardiotoxic oncologic therapies. These treatments can cause cardiovascular adverse events, including cardiac systolic dysfunction, the development of which has important clinical and prognostic implications. The availability of good predictors may enable early detection of these cardiac problems. Variables such as age, weight and height are available for each patient, as well as some measures obtained from echocardiography, a technique used prior and during the treatment to check the structure and function of the heart. Among them, there is a functional variable that measures the myocardial velocity during the cardiac cycle. For patients that experienced cancer therapy-related cardiac dysfunction during the treatment period, time until its appearance is known. This dataset aims to enable the scientific community in conducting new research on this cardiovascular side effect.

Automated summary

This dataset is a result of collaboration between two universities, containing information about 531 women with HER2+ breast cancer treated with potentially cardiotoxic therapies. The dataset aims to enable research on cardiovascular side effects and early detection of cardiac problems.